| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/09/2006 | WO2006025345A1 Antihuman baff antibody |
| 03/09/2006 | WO2006024931A2 Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator |
| 03/09/2006 | WO2006024770A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/09/2006 | WO2006024627A2 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | US20060052594 New corticosteroids |
| 03/09/2006 | US20060052451 Method |
| 03/09/2006 | US20060052433 Compound |
| 03/09/2006 | US20060052419 Use of pyridly amides as inhibitors of angiogenesis |
| 03/09/2006 | US20060052413 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/09/2006 | US20060052407 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052398 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 03/09/2006 | US20060052397 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 03/09/2006 | US20060052379 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
| 03/09/2006 | US20060052371 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 03/09/2006 | US20060052362 Skeletal muscle protecting agent |
| 03/09/2006 | US20060052336 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052313 Selective dipeptide inhibitors of kallikrein |
| 03/09/2006 | US20060052309 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 03/09/2006 | US20060051357 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and or a mtor inhibitor |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051343 Preventives remedies for bone and joint diseases |
| 03/09/2006 | US20060051316 Remedy |
| 03/09/2006 | US20060051295 Estrogen receptor interaction with a transcription factor |
| 03/09/2006 | DE10019195B4 Reversible Immortalisierung Reversible immortalization |
| 03/09/2006 | CA2576924A1 Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 03/09/2006 | CA2576839A1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 03/09/2006 | CA2576781A1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 03/08/2006 | EP1632574A1 Fibroblast growth factor homologs |
| 03/08/2006 | EP1632488A1 Cyclic tertiary amine compound |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632249A1 Osteogenesis-promotion enhancer and method of screening the same |
| 03/08/2006 | EP1631559A2 Il-8 receptor antagonists |
| 03/08/2006 | EP1631558A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| 03/08/2006 | EP1631331A1 A bioabsorbable delivery system |
| 03/08/2006 | EP1631283A1 Antiarthritic combinations |
| 03/08/2006 | EP1631266A2 A method of treating degenerative disc disease |
| 03/08/2006 | EP1631265A2 Use of various agents for inhibiting fibrous adhesions |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 03/08/2006 | EP1438341B1 Antibody stimulating il-1ra production |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 03/08/2006 | EP1294389B1 Therapeutical use of sophora flavescens or sophora subprostrata extracts |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1257581B1 Compounds related to or derived from gfr alpha 4 and their use |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP1005460B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 03/08/2006 | EP0733109B1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 03/08/2006 | CN1745085A Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1744897A Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 03/08/2006 | CN1743316A 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use |
| 03/08/2006 | CN1743000A Parathyroid hormone transnosal preparation and preparing method |
| 03/08/2006 | CN1742985A Bone-setting preparation and preparing method |
| 03/08/2006 | CN1742972A External-use medicine of Herba chloranthi multistachydis |
| 03/08/2006 | CN1742969A Pandanguo medicated liquor |
| 03/08/2006 | CN1742965A Fracture medicated liquor of mappianthus iodordes |
| 03/08/2006 | CN1742961A External-use medicine of Rhizome cyperi |
| 03/08/2006 | CN1742959A Health-care medicated pad |
| 03/08/2006 | CN1742946A Fracture medicated liquor made from Folium nerviliae cum cormo |
| 03/08/2006 | CN1742945A Liangwang-tea fracture medicated liquor |
| 03/08/2006 | CN1742944A Chinese-yeast-hops medicated liquor |
| 03/08/2006 | CN1742934A Xianlinggubao granulae preparation, and preparing method and quality control technology |
| 03/08/2006 | CN1742932A Fracture medicated liquor of sargentaglory vine |
| 03/08/2006 | CN1742930A Copper battledore medicated liquor |
| 03/08/2006 | CN1742928A Miao-Nationality medicated liquor for treating fractures and fractures from falling |
| 03/08/2006 | CN1742917A External-use medicine of caulis spatholobi |
| 03/08/2006 | CN1742911A Yanmailing fracture-treating medicated liquor |
| 03/08/2006 | CN1742910A Fracture-treating medicated liquor of Herba seu Radix peperomiae Tetraphyllate |
| 03/08/2006 | CN1742909A Fracture-treating medicated liqor of Feilian |
| 03/08/2006 | CN1742908A Fracture-treating medicated liquor of Radix cynanchi Wallichii |
| 03/08/2006 | CN1742907A External-use medicine of Radix celastri orbiculati |
| 03/08/2006 | CN1742906A Medicated liqor of Radix Oenotherae Erythrosepalae |
| 03/08/2006 | CN1742901A Medicated pad and its use |
| 03/08/2006 | CN1742899A Bong-recovering soft capsule |
| 03/08/2006 | CN1742898A Bone-recovering tablets |
| 03/08/2006 | CN1742897A Bone-recovering particles |
| 03/08/2006 | CN1742896A Bone-recovering guttate pills |
| 03/08/2006 | CN1742895A External-use medicine of Herba sarcandrae |
| 03/08/2006 | CN1742894A Medicated liquor of Radix elsholtziae Fruticosae |
| 03/08/2006 | CN1742893A Medicated liquor of Herba Tetrastigmae Yunnanensis |
| 03/08/2006 | CN1742892A Medicated liquor of Radix Tetrastigmatis Hypoglauci |
| 03/08/2006 | CN1742888A Fracture-treating medicated of Laoyahu |
| 03/08/2006 | CN1742887A Fracture-treating medicated of Herba of Radix Alyxiae Sinensis |
| 03/08/2006 | CN1742886A Medicated liquor of cortex Zanthoxyli podocarpi |
| 03/08/2006 | CN1742885A Medicated liquor of Folium premnae puberulae |
| 03/08/2006 | CN1742884A Dianduanxiang medicated liquor |
| 03/08/2006 | CN1742883A Fragrants medicated liquor for treating fractures |
| 03/08/2006 | CN1742878A Mantuoluozi medicinal liquor |